Continuing to drive innovation in endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today announced the introduction of an imaging and visualization service for endovascular specialists who use the company’s market-leading portfolio of stent grafts to treat aortic aneurysms. Aortic aneurysms affect more than one million people in the United States alone and can rupture with fatal consequences if left untreated.
Enabled by a global partnership with Vital Images (NASDAQ: VTAL), 3D Recon is a new service from Medtronic that converts two-dimensional computed tomography (CT) axial images to three-dimensional images, offering advanced visualization of the anatomy and aneurysm measurement for device sizing. This technology allows physicians to streamline pre-case planning and patient follow-up. It is cleared by the U.S. Food and Drug Administration under a 510(k) granted to Vital Images.
Vital Images is a leading provider of advanced visualization and analysis software. Its Endovascular Stent Planning application provides real-time automated clinical information specifically for the evaluation of abdominal and thoracic aortic aneurysms. The application enables removal of bone and anatomy from the image, visualization from the aortic root through the iliac bifurcation, as well as specific measurements for procedure planning. It allows vascular surgeons and interventionalists to instantly view three dimensional anatomy pre-operatively, followed by the implanted stent graft post-operatively.